Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma
about
Main roads to melanomaPhytochemicals for the Management of MelanomaFrequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.Host risk factors, ultraviolet index of residence, and incident malignant melanoma in situ among US women and men.Isolation of human epidermal layers by laser capture microdissection: application to the analysis of gene expression by quantitative real-time PCR.Clinical correlates of NRAS and BRAF mutations in primary human melanoma.Targeted therapy for melanoma: a primer.Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort.Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational studyGenetics of uveal melanoma and cutaneous melanoma: two of a kind?Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management.Novel anti-cancer compounds for developing combinatorial therapies to target anoikis-resistant tumors.Molecular testing in malignant melanoma.The sweet and bitter sides of galectins in melanoma progression.Driving transcriptional regulators in melanoma metastasis.Protein and non-protein biomarkers in melanoma: a critical update.Molecular networks in melanoma invasion and metastasis.Current research and development of chemotherapeutic agents for melanomaPD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation.PTEN functions as a melanoma tumor suppressor by promoting host immune response.Characterization of a new human melanoma cell line with CD133 expression.Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression.Targeted therapy; from advanced melanoma to the adjuvant setting.Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma.BRAF mutation status in primary and metastatic melanomas in two regions with differing potential ultraviolet radiation exposure.Melanoma cells in distinct growth phases retain specific invasive qualities during brain metastasis in vivo.Is BRAF a prognostic factor in stage III skin melanoma? A retrospective study of 72 patients after positive sentinel lymph node dissection.Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma.
P2860
Q21245465-326263A0-D5D5-4C10-AAB0-507B546C6544Q26766708-A9DC5C91-7B5D-4228-96F2-DB5511658CACQ27851617-9676CA07-EA63-4030-838A-DED8E77E2C9BQ27852445-76855C99-4E71-459B-AC99-888D1CD5015EQ33621151-AE853FFC-DE44-4C33-87E7-48A3F3BAD21BQ34310830-6ED4DBF1-8221-413E-B083-09494A9E21B0Q34500495-F9059DC2-13A8-461A-8580-28E764E902B9Q34540273-4706B335-93E1-4C89-9F49-52DD74B9AAE4Q35803185-3E47CD77-208F-4911-A6C5-20234654F00AQ37152975-2269760D-F8B4-4634-83B6-91D5DCA1BD85Q37270518-07CBD62A-F9A3-40A9-A15A-E79DC5469368Q37772777-BAC09E55-123C-4E76-B251-B9769D660A32Q37886997-ADD28617-D1BD-4601-AB89-0D4772652149Q37971860-544F3685-9EE9-4C7E-A682-E4EE9B726AE7Q38012416-8727F541-161F-4EB6-9200-7EF01E60F6E6Q38016538-FBA690D5-E3B2-4DDC-8457-A906CE4D2669Q38017594-3E55A9C4-AF9A-4A56-9DC4-3A4AD6A4B04AQ38050990-40E2F9BD-DD06-4353-96D5-174689A0B9EBQ38104416-F0FEFA35-25FD-4910-8F53-717DFF575669Q38166569-A87827DC-E3BC-4091-9913-194869EA9D9AQ38389400-8F6FC5E8-9100-42F4-93AC-2863826A1FB5Q39076276-F6B03EAD-6F31-4B8A-9DA9-4CCEDE63BA6DQ39359718-BA9BD49F-792D-42F7-A4AC-C7055682E8CDQ39609077-AE16DE53-AFDF-464B-BF25-DDD9CCBE6C95Q42172884-352B042E-9E81-4D6A-B03D-0DE9D1BA5489Q42415481-FB712615-5FC0-4C14-9453-EE683DA76728Q46574771-47884D98-133F-4C08-A387-61E196EE9D0CQ48860142-622C9DD7-0FF5-4F3C-8F7C-D92FE7BF154CQ50713886-6158A23D-A9B4-4762-9CAE-3F241D962592Q54288936-F0FBB9CC-4164-463E-A0E6-BDFD692FAC54
P2860
Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Frequencies of NRAS and BRAF m ...... th phase in cutaneous melanoma
@ast
Frequencies of NRAS and BRAF m ...... th phase in cutaneous melanoma
@en
type
label
Frequencies of NRAS and BRAF m ...... th phase in cutaneous melanoma
@ast
Frequencies of NRAS and BRAF m ...... th phase in cutaneous melanoma
@en
prefLabel
Frequencies of NRAS and BRAF m ...... th phase in cutaneous melanoma
@ast
Frequencies of NRAS and BRAF m ...... th phase in cutaneous melanoma
@en
P2093
P2860
P356
P1476
Frequencies of NRAS and BRAF m ...... th phase in cutaneous melanoma
@en
P2093
Elizabeth A Grimm
Julie A Ellerhorst
Marcella M Johnson
Victoria R Greene
P2860
P2888
P304
P356
10.1038/JID.2008.374
P407
P577
2009-06-01T00:00:00Z
P5875
P6179
1012674295